Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure.

Young-Soon YangVo Van GiauSeong Soo A AnSang Yun Kim

Published in: Dementia and neurocognitive disorders (2018)

This study showed higher plasma Aβ oligomer levels in AD patients with Agent Orange exposure compared to AD patients without Agent Orange. This finding suggests the possibility of a different pathophysiology of AD patients with Agent Orange exposure from AD patients without Agent Orange.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes